ArticleACS omega2023
Preparation and Characterization of Avermectin B2 Microcapsules and Effective Control of Root-Knot Nematodes.
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Potential ofMetabolites · 2024Review
- Preparation, Characterization, and Bioactivity Evaluation of Lambda-Cyhalothrin Microcapsules for Slow-Controlled Release System.ACS omega · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyurethane microcapsules of avermectin B2 were prepared by means of interfacial polymerization with methylene diphenyl diisocyanate as the wall material and triethanolamine as the initiator. The microcapsules were characterized by scanning electron microscopy, Fourier transform infrared spectroscopy, and thermogravimetric analysis. The surfaces of the microcapsules were found to be smooth and almost spherical, and the encapsulation efficiency was high. The avermectin B2 microcapsules exhibited a good diffusion-controlled sustained-release performance, giving a cumulative release rate of 91.81%. The results indicated that the polyurethane capsule protected against the photolysis of avermectin B2. Finally, the microcapsules exhibited good soil leaching properties and were able to control the population of root-knot nematodes with an efficacy of 80.80%.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.